DVA:NYSE
Davita Inc
179,25 US$
arrow_upward
+1,26%(+2,23) 1K
179,25 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:03 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoDVA tikeri uchun statistika yaratilmoqda...
Ochish
177,00 US$
Yuqori
180,11 US$
Past
177,00 US$
Bozor kapitali
11,44 mlrd
Oʻrtacha hajm
659,00 ming
Hajmi
369,64 ming
P/E koeffitsiyenti
14,68
52 haftalik eng yuqori
247,49 US$
52 haftalik eng past
101,00 US$
Aksiya boʻyicha daromad
12,21 US$
Beta
0,80
Muomaladagi aksiyalar
63,80 mln
Xodimlar soni
78 ming
Ochish
177,00 US$
Yuqori
180,11 US$
Past
177,00 US$
Bozor kapitali
11,44 mlrd
Oʻrtacha hajm
659,00 ming
Hajmi
369,64 ming
P/E koeffitsiyenti
14,68
52 haftalik eng yuqori
247,49 US$
52 haftalik eng past
101,00 US$
Aksiya boʻyicha daromad
12,21 US$
Beta
0,80
Muomaladagi aksiyalar
63,80 mln
Xodimlar soni
78 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
2 kun oldin
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
News Corp
·
2 kun oldin
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains
Seeking Alpha
·
2 kun oldin
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again (NYSE:DVA)
Zacks
·
2 kun oldin
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
Profil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Davita Inc haqida
CEOJavier J. Rodriguez
Xodimlar soni78 ming
Asos solingan1992
Bosh ofislarDenver, Kolorado, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Veb-saytdavita.com